Navigation Links
Pharmacopeia and GlaxoSmithKline Collaboration Identifies Two Additional Lead Compounds
Date:11/27/2007

Lead Selections Trigger Milestone Payments Totaling $1 Million to

Pharmacopeia

PRINCETON, N.J., Nov. 27 /PRNewswire-FirstCall/ -- Pharmacopeia (Nasdaq: PCOP), an innovator in the discovery and development of novel small molecule therapeutics, announced today that it has identified two new lead compounds for advancement in its alliance with GlaxoSmithKline (NYSE: GSK), through its collaboration with the Center of Excellence for External Drug Discovery (CEEDD). The first of the lead compounds forms the basis of a new lead optimization program focused on identifying a treatment for respiratory disease. The other newly identified lead compound is the second from a program in inflammatory pain. As a result of the identification of these new lead compounds, Pharmacopeia will receive milestone payments totaling $1 million from GSK.

Under the terms of the companies' collaboration, Pharmacopeia has received $10 million from GSK in connection with early discovery activities and is entitled to an additional $5 million payment upon the completion of additional early discovery activities. Pharmacopeia is also entitled to success-based milestone payments totaling up to $83 million per program and potentially double-digit royalties on the sales of any product commercialized by GSK under the multi-program alliance. Should GSK decline its option to complete pivotal trials of alliance programs, Pharmacopeia may independently pursue them, subject to its obligations to GSK under the agreement.

"With the identification of these two compounds, our collaboration has now identified a total of three new leads this year," said Hugh Cowley, Senior Vice President of GSK and head of the CEED
'/>"/>

SOURCE Pharmacopeia
Copyright©2007 PR Newswire.
All rights reserved

Page: 1 2 3 4 5

Related medicine news :

1. Pharmacopeia Announces Senior Additions to Management Team
2. Pharmacopeia Acquires Selective Androgen Receptor Modulator (SARM) Program from Bristol-Myers Squibb
3. GlaxoSmithKline Responds to JAMA Articles
4. MedImmune Licenses Reverse Genetics Technology to GlaxoSmithKline for Use in Influenza Vaccine Development and Production
5. Congressional Black Caucus Foundation and GlaxoSmithKline Announce Supplier Business Initiative Study Results
6. AUDIO from Medialink and GlaxoSmithKline: A New Nasal Spray for Allergy Relief
7. Mylan Announces Settlement of Paroxetine Hydrochloride Extended-Release Tablets with GlaxoSmithKline
8. GlaxoSmithKline Aids California Fire Relief Efforts
9. Genmab and GlaxoSmithKline Initiate Ofatumumab Rheumatoid Arthritis Phase III Program
10. GlaxoSmithKline Obtains Exclusive U.S. OTC Marketing Rights to MEVACOR(R) (lovastatin) from Merck & Co., Inc.
11. Milestone Scientific Announces Successful Completion of its Collaboration Agreement With Carticept Medical
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/29/2015)... (PRWEB) May 29, 2015 Designed with ... teamed up to create an all new, exclusive line ... a formulated with the latest and greatest, high impact, ... proven to be effective. The 24/7 Series can be ... cross-fitters and even the casual fitness enthusiasts. There are ...
(Date:5/29/2015)... Texas (PRWEB) May 29, 2015 The annual ... Plastic Surgery (ASAPS), was held in Montreal from May 14-19th. ... education for aesthetic professionals from around the world; dedicating itself ... of the many renowned plastic surgeons to attend ... during the six-day event, Dr. Vitenas was given the honor ...
(Date:5/29/2015)... May 29, 2015 The ... 2015” provides comprehensive information on the therapeutic ... R&D pipelines by identifying new targets and ... Complete report on H1 2015 pipeline review ... tables and 13 figures, spread across 47 ...
(Date:5/29/2015)... May 29, 2015 External Counterpulsation, also known ... disease treatment for patients. The Heart Fit Clinic is the ... released a raving review from patients who are now completing ... and underwent 35 treatments of ECP treatment and received great ... here. Not only does the clinic perform this non-surgical treatment ...
(Date:5/29/2015)... Ohio (PRWEB) May 29, 2015 DISC, ... between personality type and behavior, is used by companies ... increase productivity. What was once considered an out-of-the-box practice, ... infrastructure. A recent poll from the Society for Human ... considered personality assessments like DISC to be an essential ...
Breaking Medicine News(10 mins):Health News:BPI Sports and Bodybuilding.com Partner Up to Bring an Innovative New Line of Supplements 2Health News:BPI Sports and Bodybuilding.com Partner Up to Bring an Innovative New Line of Supplements 3Health News:Dr. Paul Vitenas Presents at 2015 Aesthetic Meeting 2Health News:Dr. Paul Vitenas Presents at 2015 Aesthetic Meeting 3Health News:Axillary Hyperhidrosis Therapeutic Assessment Pipeline Review H1 2015 Market Research Report Available at RnRMarketResearch.com 2Health News:Axillary Hyperhidrosis Therapeutic Assessment Pipeline Review H1 2015 Market Research Report Available at RnRMarketResearch.com 3Health News:External Counterpulsation at Heart Fit Clinic Receives Raving Review 2Health News:PeopleKeys to Air a Follow-up to Their Popular DISC Trainer’s Toolbox Webinar, Featuring All-New Content and Strategies 2
... dressing well given by an emergency doctor. There is no need ... cold. A brisk walk and exposure to sunlight will do you ... you want to avoid the ill-effects of cold weather. Just putting ... the answer. ,Dr Goerge Danke, professor of emergency medicine ...
... According to new study, a protein in the eye has ... researchers say this could lead to promising treatments for other// ... ,Scientists from the Schepens Eye Research Institute in Boston ... a therapeutic drug. The drug can then prevent the onset ...
... that breathing oxygen may cause some harm to cells. The ... people //with severe lung or heart disease.Oxygen supports the organs ... the blood. But oxygen is often given inappropriately. Overall the ... life'. ,A study by researchers at New York Medical ...
... at University of Illinois at Chicago could possibly help ... Dean of the College of Nursing at UIC, //and ... which is using warm booties as a way to ... The idea, says Shaver, is that better sleep occurs ...
... loss followed by weight gain is only a health risk ... are now well established to many. But weight, once lost,// ... that fluctuating weight may, in itself, predispose to heart disease ... a group of 5,428 middle-aged British men during a 12 ...
... observed that yoga therapy can reduce risk factors and improve ... aid improve physical, psychological and spiritual //health - or so ... England, reviewed the best evidence they could find on the ... - out of 11 - trials that were good enough ...
Cached Medicine News:
(Date:5/28/2015)... Md. , May 28, 2015 ... it will be a supporting organization of the ... and sterilization in 2016. Johnson & ... series of high-profile superbug infections in endoscopes. J&J ... health issues between 1976 and 2003 on advances ...
(Date:5/28/2015)... May 28, 2015   Mast Therapeutics, Inc. ... leveraging its molecular adhesion and sealant technology (MAST) ... disease, heart failure, and arterial disease, today announced ... Company,s Board of Directors. Mr. Lief made this ... given his role as President and Chief Executive ...
(Date:5/28/2015)... 2015 Compassion & Choices today is pleased to ... that would authorize the option of medical aid in dying ... The legislation, the ... mentally competent adults with six months or less to live ... painlessly and peacefully end an unbearable dying process. A vote ...
Breaking Medicine Technology:PDA Announces Support for the Johnson & Johnson Kilmer Conference 2Mast Therapeutics Announces Change In Board Of Directors 2Mast Therapeutics Announces Change In Board Of Directors 3Mast Therapeutics Announces Change In Board Of Directors 4California Committee Sends Medical Aid-in-Dying Bill to Senate Floor 2California Committee Sends Medical Aid-in-Dying Bill to Senate Floor 3
... 13 Rcadia Medical Imaging today announced that ... of coronary CT angiography (cCTA) will be featured in ... scientific meeting of the Society of Cardiovascular Computed Tomography ... .  SCCT is the international professional society representing physicians, ...
... FOREST, Ill. , July 13 ... leading provider of clinical information and medication delivery technologies, ... clinical surveillance system helped clinicians at Memorial ... an increase in infection-control interventions. The hospital, which used ...
Cached Medicine Technology:Rcadia Announces Five COR Analyzer® Studies to be Presented at SCCT Annual Scientific Meeting 2Rcadia Announces Five COR Analyzer® Studies to be Presented at SCCT Annual Scientific Meeting 3Hospira TheraDoc(TM) Infection Control Assistant(TM) Documents Interventions to Help Hospital Reduce Catheter-Related Infections 2Hospira TheraDoc(TM) Infection Control Assistant(TM) Documents Interventions to Help Hospital Reduce Catheter-Related Infections 3Hospira TheraDoc(TM) Infection Control Assistant(TM) Documents Interventions to Help Hospital Reduce Catheter-Related Infections 4Hospira TheraDoc(TM) Infection Control Assistant(TM) Documents Interventions to Help Hospital Reduce Catheter-Related Infections 5Hospira TheraDoc(TM) Infection Control Assistant(TM) Documents Interventions to Help Hospital Reduce Catheter-Related Infections 6
Clearview Chlamydia is a rapid, easy-to-use test for the detection of Chlamydia trachomatis from female endocervical swab specimens....
10-mm (0.4-in) diameter cups have multi-color lead wires and 2-mm (0.08-in) holes for easy paste/collodion application. Available in a variety of lengths to suit many different needs....
... head cap systems are packaged to provide ... Electro-Cap System features pure tin electrodes positioned ... you place your order, please specify which ... cap system and whether you want regular ...
... The Bio-eye hydroxyapatite (HA) orbital implant was ... the early 1980s, after a comprehensive review ... included the earliest manuscripts dating back to ... an ongoing dissatisfaction with the performance of ...
Medicine Products: